What Human Genetic Modification Means for Women: Supporters of the New Eugenics Want It Framed as an Issue of "Choice." but Feminists Know We Can Support Abortion Rights and Still Oppose Eugenics. (the Risks of the Rush)

By Levine, Judith | World Watch, July-August 2002 | Go to article overview

What Human Genetic Modification Means for Women: Supporters of the New Eugenics Want It Framed as an Issue of "Choice." but Feminists Know We Can Support Abortion Rights and Still Oppose Eugenics. (the Risks of the Rush)


Levine, Judith, World Watch


Supporters of the new eugenics want it trained as an issue of "choice." But feminists know we can support abortion rights and still oppose eugenics.

Seduced by the medical promises of genetic science or fearful of losing reproductive autonomy, many feminists have been slow to oppose human genetic engineering. But GE is a threat to women, and in the broadest sense a feminist issue. Here's why.

If anyone should be wary of medical techniques to "improve" ordinary reproduction--as GE purports to do--it's women. History is full of such "progress," and its grave results. When limbless babies were born to mothers who took thalidomide, the drug was recalled. But the deadly results of another "pregnancy-enhancing" drug, DES, showed up only years later, as cancer in the daughters of DES mothers. The high-estrogen Pill was tested first on uninformed Puerto Rican mothers, some of whom may have died from it.

Today's fertility industry takes in $4 billion a year, even though in-vitro fertilization (IVF) succeeds in only 3 of 10 cases. Virtually unregulated and highly competitive, these fertility doctors often undertake experimental treatments. Recently, the Institute for Reproductive Medicine and Science at New Jersey's St. Barnabas Medical Center announced the success of a new fertility "therapy" called cytoplasmic transfer, in which some of the cellular material outside the nucleus of one woman's egg is transferred into the egg of another woman who is having difficulty sustaining embryo survival. The transferred cytoplasm contains mitochondria (organelles that produce energy for the cell), which have a small number of their own genes. So the embryo produced with cytoplasmic transfer can end up with two genetic mothers. This mixing, called "mitochondrial hetroplasmy," can cause life-threatening symptoms that don't show up until later in life. When the Public Broadcasting Service's Nova enthusiastically reported o n the procedure, complete with footage of its cute outcome, Katy, it mentioned no risks.

Didn't these patients give informed consent? Yes and no. Most read warnings and signed their names. But with genetic therapies there's no such thing as "informed," says Judy Norsigian of the Boston Women's Health Collective, "because the risks can't be known." Adds biologist Ruth Hubbard, the deadliness of DES was discovered "only because it showed itself in an otherwise very rare condition. If the effects [of human genetic engineering] are delayed, and if they are not associated with a particularly unusual pathology, it could take quite a long time to find out." Or indeed, "we might never know."

"PERFECTING" HUMAN GENETIC MODIFICATION WOULD REQUIRE EXPERIMENTATION ON WOMEN AND CHILDREN.

Scottish biologist Ian Wilmut, the "father" of the famously first-cloned sheep Dolly, provided these statistics in 2001: Of the 31,007 sheep, mice, pig, and other mammal eggs that had undergone somatic cell nuclear transfer (cloning), 9,391 viable embryos resulted. From those embryos came 267 live-born offspring. In these animals, The New York Times reported, "random errors" were ubiquitous--including fatal heart and lung defects, malfunctioning immune systems, and grotesque obesity. In all, "fewer than 3 percent of all cloning efforts succeed." Dolly may be a victim of accelerated aging, another problem in cloned animals. In January, it was reported that she has arthritis, at the unusually early age of five and a half. Mothers of clones are endangered too, since their bodies have trouble supporting the abnormally large fetuses that cloning often produces.

It's likely that scientists will get better at cloning animals, and at the more complex procedures required to produce inheritable genetic alterations. Then, as health activists quip, if it works on a mouse, they will try it on a woman. The problem, warns Stuart Newman, a cell biologist at New York Medical College in Valhalla, is that if it works on a mouse, it is likely not to work on a woman: "Every species presents a new set of problems. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

What Human Genetic Modification Means for Women: Supporters of the New Eugenics Want It Framed as an Issue of "Choice." but Feminists Know We Can Support Abortion Rights and Still Oppose Eugenics. (the Risks of the Rush)
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.